Selected research
Industry Research
Cosmetic Peptide Manufacturing Industry Research Report 2026
Market perspective
The global Cosmetic Peptide Manufacturing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cosmetic Peptide Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cosmetic Peptide Manufacturing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cosmetic Peptide Manufacturing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cosmetic Peptide Manufacturing include Croda International PIc, Ashland, DSM [Koninklijke DSM NV], Bachem, Genscript Biotech Corp, BASF SE, Geltor, The Lubrizol Corporation and Symrise, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cosmetic Peptide Manufacturing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cosmetic Peptide Manufacturing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cosmetic Peptide Manufacturing Market by Company
Croda International PIc
Ashland
DSM [Koninklijke DSM NV]
Bachem
Genscript Biotech Corp
BASF SE
Geltor
The Lubrizol Corporation
Symrise
Bio basic Inc.
Regeron Inc.
Merck KGaA
RS Synthesis, LLC
CSBio Company Inc.
Creative Peptides
Spec Chem Industry Inc.
LipoTrue, SL
Fibroheal
Seiwa Kasei Co., Ltd.
Silab
Cosmetic Peptide Manufacturing Segment by Type
Signal Peptides
Neurotransmitter Inhibitors
Carrier Peptides
Enzyme Inhibitor Peptides
Structural Peptides
Synthetic Antimicrobial Peptides (Amps)
Others
Cosmetic Peptide Manufacturing Segment by Application
Cosmetic Manufacturers
Cosmetic Contract Manufacturers
Biopharmaceutical Industries (Personal Care)
Cosmetic Peptide Manufacturing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cosmetic Peptide Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cosmetic Peptide Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cosmetic Peptide Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cosmetic Peptide Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Signal Peptides
- Neurotransmitter Inhibitors
- Carrier Peptides
- Enzyme Inhibitor Peptides
- Structural Peptides
- Synthetic Antimicrobial Peptides (Amps)
- Others
Applications
- Cosmetic Manufacturers
- Cosmetic Contract Manufacturers
- Biopharmaceutical Industries (Personal Care)
Companies covered
- Croda International PIc
- Ashland
- DSM [Koninklijke DSM NV]
- Bachem
- Genscript Biotech Corp
- BASF SE
- Geltor
- The Lubrizol Corporation
- Symrise
- Bio basic Inc.
- Regeron Inc.
- Merck KGaA
- RS Synthesis, LLC
- CSBio Company Inc.
- Creative Peptides
- Spec Chem Industry Inc.
- LipoTrue, SL
- Fibroheal
- Seiwa Kasei Co., Ltd.
- Silab
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cosmetic Peptide Manufacturing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Signal Peptides
- 2.2.3 Neurotransmitter Inhibitors
- 2.2.4 Carrier Peptides
- 2.2.5 Enzyme Inhibitor Peptides
- 2.2.6 Structural Peptides
- 2.2.7 Synthetic Antimicrobial Peptides (Amps)
- 2.2.8 Others
- 2.3 Cosmetic Peptide Manufacturing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cosmetic Manufacturers
- 2.3.3 Cosmetic Contract Manufacturers
- 2.3.4 Biopharmaceutical Industries (Personal Care)
- 2.4 Assumptions and Limitations
3 Cosmetic Peptide Manufacturing Breakdown Data by Type
- 3.1 Global Cosmetic Peptide Manufacturing Historic Market Size by Type (2021-2026)
- 3.2 Global Cosmetic Peptide Manufacturing Forecasted Market Size by Type (2027-2032)
4 Cosmetic Peptide Manufacturing Breakdown Data by Application
- 4.1 Global Cosmetic Peptide Manufacturing Historic Market Size by Application (2021-2026)
- 4.2 Global Cosmetic Peptide Manufacturing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cosmetic Peptide Manufacturing Market Perspective (2021-2032)
- 5.2 Global Cosmetic Peptide Manufacturing Growth Trends by Region
- 5.2.1 Global Cosmetic Peptide Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cosmetic Peptide Manufacturing Historic Market Size by Region (2021-2026)
- 5.2.3 Cosmetic Peptide Manufacturing Forecasted Market Size by Region (2027-2032)
- 5.3 Cosmetic Peptide Manufacturing Market Dynamics
- 5.3.1 Cosmetic Peptide Manufacturing Industry Trends
- 5.3.2 Cosmetic Peptide Manufacturing Market Drivers
- 5.3.3 Cosmetic Peptide Manufacturing Market Challenges
- 5.3.4 Cosmetic Peptide Manufacturing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cosmetic Peptide Manufacturing Players by Revenue
- 6.1.1 Global Top Cosmetic Peptide Manufacturing Players by Revenue (2021-2026)
- 6.1.2 Global Cosmetic Peptide Manufacturing Revenue Market Share by Players (2021-2026)
- 6.2 Global Cosmetic Peptide Manufacturing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cosmetic Peptide Manufacturing Head Office and Area Served
- 6.4 Global Cosmetic Peptide Manufacturing Players, Product Type & Application
- 6.5 Global Cosmetic Peptide Manufacturing Manufacturers Established Date
- 6.6 Global Cosmetic Peptide Manufacturing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cosmetic Peptide Manufacturing Market Size (2021-2032)
- 7.2 North America Cosmetic Peptide Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cosmetic Peptide Manufacturing Market Size by Country (2021-2026)
- 7.4 North America Cosmetic Peptide Manufacturing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cosmetic Peptide Manufacturing Market Size (2021-2032)
- 8.2 Europe Cosmetic Peptide Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cosmetic Peptide Manufacturing Market Size by Country (2021-2026)
- 8.4 Europe Cosmetic Peptide Manufacturing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cosmetic Peptide Manufacturing Market Size (2021-2032)
- 9.2 Asia-Pacific Cosmetic Peptide Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cosmetic Peptide Manufacturing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cosmetic Peptide Manufacturing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cosmetic Peptide Manufacturing Market Size (2021-2032)
- 10.2 South America Cosmetic Peptide Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cosmetic Peptide Manufacturing Market Size by Country (2021-2026)
- 10.4 South America Cosmetic Peptide Manufacturing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cosmetic Peptide Manufacturing Market Size (2021-2032)
- 11.2 Middle East & Africa Cosmetic Peptide Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cosmetic Peptide Manufacturing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cosmetic Peptide Manufacturing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Croda International PIc
- 12.1.1 Croda International PIc Company Information
- 12.1.2 Croda International PIc Business Overview
- 12.1.3 Croda International PIc Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.1.4 Croda International PIc Cosmetic Peptide Manufacturing Product Portfolio
- 12.1.5 Croda International PIc Recent Developments
- 12.2 Ashland
- 12.2.1 Ashland Company Information
- 12.2.2 Ashland Business Overview
- 12.2.3 Ashland Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.2.4 Ashland Cosmetic Peptide Manufacturing Product Portfolio
- 12.2.5 Ashland Recent Developments
- 12.3 DSM [Koninklijke DSM NV]
- 12.3.1 DSM [Koninklijke DSM NV] Company Information
- 12.3.2 DSM [Koninklijke DSM NV] Business Overview
- 12.3.3 DSM [Koninklijke DSM NV] Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.3.4 DSM [Koninklijke DSM NV] Cosmetic Peptide Manufacturing Product Portfolio
- 12.3.5 DSM [Koninklijke DSM NV] Recent Developments
- 12.4 Bachem
- 12.4.1 Bachem Company Information
- 12.4.2 Bachem Business Overview
- 12.4.3 Bachem Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.4.4 Bachem Cosmetic Peptide Manufacturing Product Portfolio
- 12.4.5 Bachem Recent Developments
- 12.5 Genscript Biotech Corp
- 12.5.1 Genscript Biotech Corp Company Information
- 12.5.2 Genscript Biotech Corp Business Overview
- 12.5.3 Genscript Biotech Corp Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.5.4 Genscript Biotech Corp Cosmetic Peptide Manufacturing Product Portfolio
- 12.5.5 Genscript Biotech Corp Recent Developments
- 12.6 BASF SE
- 12.6.1 BASF SE Company Information
- 12.6.2 BASF SE Business Overview
- 12.6.3 BASF SE Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.6.4 BASF SE Cosmetic Peptide Manufacturing Product Portfolio
- 12.6.5 BASF SE Recent Developments
- 12.7 Geltor
- 12.7.1 Geltor Company Information
- 12.7.2 Geltor Business Overview
- 12.7.3 Geltor Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.7.4 Geltor Cosmetic Peptide Manufacturing Product Portfolio
- 12.7.5 Geltor Recent Developments
- 12.8 The Lubrizol Corporation
- 12.8.1 The Lubrizol Corporation Company Information
- 12.8.2 The Lubrizol Corporation Business Overview
- 12.8.3 The Lubrizol Corporation Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.8.4 The Lubrizol Corporation Cosmetic Peptide Manufacturing Product Portfolio
- 12.8.5 The Lubrizol Corporation Recent Developments
- 12.9 Symrise
- 12.9.1 Symrise Company Information
- 12.9.2 Symrise Business Overview
- 12.9.3 Symrise Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.9.4 Symrise Cosmetic Peptide Manufacturing Product Portfolio
- 12.9.5 Symrise Recent Developments
- 12.10 Bio basic Inc.
- 12.10.1 Bio basic Inc. Company Information
- 12.10.2 Bio basic Inc. Business Overview
- 12.10.3 Bio basic Inc. Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.10.4 Bio basic Inc. Cosmetic Peptide Manufacturing Product Portfolio
- 12.10.5 Bio basic Inc. Recent Developments
- 12.11 Regeron Inc.
- 12.11.1 Regeron Inc. Company Information
- 12.11.2 Regeron Inc. Business Overview
- 12.11.3 Regeron Inc. Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.11.4 Regeron Inc. Cosmetic Peptide Manufacturing Product Portfolio
- 12.11.5 Regeron Inc. Recent Developments
- 12.12 Merck KGaA
- 12.12.1 Merck KGaA Company Information
- 12.12.2 Merck KGaA Business Overview
- 12.12.3 Merck KGaA Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.12.4 Merck KGaA Cosmetic Peptide Manufacturing Product Portfolio
- 12.12.5 Merck KGaA Recent Developments
- 12.13 RS Synthesis, LLC
- 12.13.1 RS Synthesis, LLC Company Information
- 12.13.2 RS Synthesis, LLC Business Overview
- 12.13.3 RS Synthesis, LLC Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.13.4 RS Synthesis, LLC Cosmetic Peptide Manufacturing Product Portfolio
- 12.13.5 RS Synthesis, LLC Recent Developments
- 12.14 CSBio Company Inc.
- 12.14.1 CSBio Company Inc. Company Information
- 12.14.2 CSBio Company Inc. Business Overview
- 12.14.3 CSBio Company Inc. Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.14.4 CSBio Company Inc. Cosmetic Peptide Manufacturing Product Portfolio
- 12.14.5 CSBio Company Inc. Recent Developments
- 12.15 Creative Peptides
- 12.15.1 Creative Peptides Company Information
- 12.15.2 Creative Peptides Business Overview
- 12.15.3 Creative Peptides Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.15.4 Creative Peptides Cosmetic Peptide Manufacturing Product Portfolio
- 12.15.5 Creative Peptides Recent Developments
- 12.16 Spec Chem Industry Inc.
- 12.16.1 Spec Chem Industry Inc. Company Information
- 12.16.2 Spec Chem Industry Inc. Business Overview
- 12.16.3 Spec Chem Industry Inc. Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.16.4 Spec Chem Industry Inc. Cosmetic Peptide Manufacturing Product Portfolio
- 12.16.5 Spec Chem Industry Inc. Recent Developments
- 12.17 LipoTrue, SL
- 12.17.1 LipoTrue, SL Company Information
- 12.17.2 LipoTrue, SL Business Overview
- 12.17.3 LipoTrue, SL Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.17.4 LipoTrue, SL Cosmetic Peptide Manufacturing Product Portfolio
- 12.17.5 LipoTrue, SL Recent Developments
- 12.18 Fibroheal
- 12.18.1 Fibroheal Company Information
- 12.18.2 Fibroheal Business Overview
- 12.18.3 Fibroheal Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.18.4 Fibroheal Cosmetic Peptide Manufacturing Product Portfolio
- 12.18.5 Fibroheal Recent Developments
- 12.19 Seiwa Kasei Co., Ltd.
- 12.19.1 Seiwa Kasei Co., Ltd. Company Information
- 12.19.2 Seiwa Kasei Co., Ltd. Business Overview
- 12.19.3 Seiwa Kasei Co., Ltd. Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.19.4 Seiwa Kasei Co., Ltd. Cosmetic Peptide Manufacturing Product Portfolio
- 12.19.5 Seiwa Kasei Co., Ltd. Recent Developments
- 12.20 Silab
- 12.20.1 Silab Company Information
- 12.20.2 Silab Business Overview
- 12.20.3 Silab Revenue in Cosmetic Peptide Manufacturing Business (2021-2026)
- 12.20.4 Silab Cosmetic Peptide Manufacturing Product Portfolio
- 12.20.5 Silab Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst